Literature DB >> 16877303

Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia.

Melissa J Churchill1, Anna Figueiredo, Daniel Cowley, Lachlan Gray, Damian Fj Purcell, John S Sullivan, Dale A McPhee, Steven L Wesselingh, Bruce J Brew, Paul R Gorry.   

Abstract

The authors studied the transcriptional activity of blood-and cerebrospinal fluid (CSF)-derived nef/long-terminal repeat (LTR) sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia (HIVD). The transcriptional activity of CSF-derived nef/LTR clones isolated during HIVD was up to 4.5-fold higher than blood-derived clones isolated before and during HIVD when tested under basal, phorbol 12-myristate 13-acetate-(PMA-), and Tat-activated conditions, and was associated with the presence of duplicated nuclear factor (NF)-kappaB and specificity factor-1 (Sp-1) binding sites coupled with a truncated nef sequence, increased replication capacity, and high CSF viral load. Thus, nef and LTR mutations that augment transcription may contribute to neuropathogenesis of nef-deleted HIV-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877303     DOI: 10.1080/13550280600827369

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  58 in total

1.  In vivo replication kinetics of a nef-deleted strain of HIV-1.

Authors:  Suzanne M Crowe; David D Ho; Debbie Marriott; Bruce Brew; Paul R Gorry; John S Sullivan; Jenny Learmont; John Mills
Journal:  AIDS       Date:  2005-05-20       Impact factor: 4.177

2.  Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains.

Authors:  J T Shieh; J Martín; G Baltuch; M H Malim; F González-Scarano
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Authors:  M C Strain; S Letendre; S K Pillai; T Russell; C C Ignacio; H F Günthard; B Good; D M Smith; S M Wolinsky; M Furtado; J Marquie-Beck; J Durelle; I Grant; D D Richman; T Marcotte; J A McCutchan; R J Ellis; J K Wong
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.

Authors:  R Mariani; F Kirchhoff; T C Greenough; J L Sullivan; R C Desrosiers; J Skowronski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

Review 6.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

7.  Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.

Authors:  Julio Martín-García; Simon Cocklin; Irwin M Chaiken; Francisco González-Scarano
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.

Authors:  Theresa K Smit; Bruce J Brew; Wallace Tourtellotte; Susan Morgello; Benjamin B Gelman; Nitin K Saksena
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Both virus and host components are important for the manifestation of a Nef- phenotype in HIV-1 and HIV-2.

Authors:  M A Ryan-Graham; K W Peden
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  6 in total

1.  CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.

Authors:  Lachlan R Gray; Dana Gabuzda; Daniel Cowley; Anne Ellett; Lisa Chiavaroli; Steven L Wesselingh; Melissa J Churchill; Paul R Gorry
Journal:  J Neurovirol       Date:  2010-11-30       Impact factor: 2.643

2.  Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro.

Authors:  Myosotys Rodriguez; Ajeet Kaushik; Jessica Lapierre; Seth M Dever; Nazira El-Hage; Madhavan Nair
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-10       Impact factor: 4.147

3.  Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.

Authors:  Myosotys Rodriguez; Jessica Lapierre; Chet Raj Ojha; Ajeet Kaushik; Elena Batrakova; Fatah Kashanchi; Seth M Dever; Madhavan Nair; Nazira El-Hage
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

4.  Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders.

Authors:  Hailong Li; Kristen A McLaurin; Jessica M Illenberger; Charles F Mactutus; Rosemarie M Booze
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

5.  Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Authors:  Paul R Gorry; Dale A McPhee; Erin Verity; Wayne B Dyer; Steven L Wesselingh; Jennifer Learmont; John S Sullivan; Michael Roche; John J Zaunders; Dana Gabuzda; Suzanne M Crowe; John Mills; Sharon R Lewin; Bruce J Brew; Anthony L Cunningham; Melissa J Churchill
Journal:  Retrovirology       Date:  2007-09-23       Impact factor: 4.602

6.  Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.

Authors:  Amit Kumar; Wasim Abbas; Laurence Colin; Kashif Aziz Khan; Sophie Bouchat; Audrey Varin; Anis Larbi; Jean-Stéphane Gatot; Kabamba Kabeya; Caroline Vanhulle; Nadège Delacourt; Sébastien Pasquereau; Laurie Coquard; Alexandra Borch; Renate König; Nathan Clumeck; Stephane De Wit; Olivier Rohr; Christine Rouzioux; Tamas Fulop; Carine Van Lint; Georges Herbein
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.